Addition of Oral Fosfomycin to Antimicrobial Salvage Therapy for Persistent Vancomycin-Resistant Enterococcal Bacteremia

Clin Infect Dis. 2022 May 3;74(9):1710-1711. doi: 10.1093/cid/ciab832.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia* / drug therapy
  • Fosfomycin* / therapeutic use
  • Gram-Positive Bacterial Infections* / drug therapy
  • Humans
  • Salvage Therapy
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Fosfomycin
  • Vancomycin